Home » Healthcare Sector » Page 6

Tag

Healthcare Sector

Articles, news and analysis on growth businesses operating in the healthcare sector.

News

IBL to acquire EKF-diagnostic

International Brand Licensing has agreed to acquire German EKF-diagnostic for £11.8 million.

Growth Planning

A hip turnaround

New CEO Peter Huntley is determined to revive the fortunes of hip and knee transplant company Corin.

News

ImmuPharma sells shares

Drug discoverer ImmuPharma’s chairman and chief executive have sold £10.75 million of shares to M&G and other institutions.

News

Neoss gets teeth into £5.5 million 

Privately owned Neoss, a developer of dental implants based in Harrogate, has secured £5.5 million to fund research and development and global sales expansion.

Entrepreneurs

Rising star: Marc Koska

Marc Koska spent 24 years working on his single-use syringe, which is designed to reduce the spread of disease in poor countries. His company Star Syringe is now profitable with revenues of £1.5 million

News

Positive vision for healthcare deals

Whether the numbers are up or down, strategic buyers are still in the market for deals. Andrew MacLeod reports

News

NeutraHealth’s Perrigo deal

NeutraHealth has become the UK's largest provider of private-label vitamins and supplements after buying one of its rivals.

News

Neoss raises £10 million

Dental implant company Neoss has completed a £10 million round of funding from venture capital firm MM Ventures, its sixth from the investor.

Mergers & Acquisitions

Healthcare enjoys deal bonanza

With the private sector increasingly taking over providing healthcare facilities, entrepreneurs and private equity firms are taking advantage of opportunities to make some serious cash.

News

Chief executive buys CliniSys

A developer of software designed to support healthcare professionals has been bought by its chief executive. CliniSys, which specialises in laboratory information management systems, was sold to a team led by Fiona Pearson.

News

ImmuPharma plots reversal

Drug developer ImmuPharma, which is focusing its efforts on converting small peptides into clinically viable compounds, hopes to launch on AIM on Friday – after raising £2.2 million from investors with the aid of broker KBC Peel Hunt.

News

Quester’s flu boost

A company in which technology specialist VCT manager Quester has invested stands to receive a boost from rising fears over a possible Avian flu outbreak. The investment group backed PowderMed via the Isis College Fund it manages, in an initial £20 million fundraising in May 2004.

Recommended Content